Sentinel node-positivt melanom

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Sentinel node-positivt melanom. / Haldrup, Mette; Stolle, Lars B; Hölmich, Lisbeth Rosenkrantz; Chakera, Annette.

In: Ugeskrift for Laeger, Vol. 180, No. 41, V03180192, 2018.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Haldrup, M, Stolle, LB, Hölmich, LR & Chakera, A 2018, 'Sentinel node-positivt melanom', Ugeskrift for Laeger, vol. 180, no. 41, V03180192. <http://ugeskriftet.dk/videnskab/sentinel-node-positivt-melanom>

APA

Haldrup, M., Stolle, L. B., Hölmich, L. R., & Chakera, A. (2018). Sentinel node-positivt melanom. Ugeskrift for Laeger, 180(41), [V03180192]. http://ugeskriftet.dk/videnskab/sentinel-node-positivt-melanom

Vancouver

Haldrup M, Stolle LB, Hölmich LR, Chakera A. Sentinel node-positivt melanom. Ugeskrift for Laeger. 2018;180(41). V03180192.

Author

Haldrup, Mette ; Stolle, Lars B ; Hölmich, Lisbeth Rosenkrantz ; Chakera, Annette. / Sentinel node-positivt melanom. In: Ugeskrift for Laeger. 2018 ; Vol. 180, No. 41.

Bibtex

@article{7663dc4efce1446bb86e9ae2e16d9b2e,
title = "Sentinel node-positivt melanom",
abstract = "Two recent randomised studies found no survival difference in patients, who had melanoma with metastasis to the sentinel node (SN) and underwent immediate complete lymph node dissection (CLND), compared with patients, who were followed closely with ultrasound scans and only underwent CLND if metastases developed. From 2018, the Danish guidelines concur: SN-positive patients will no longer undergo routine CLND, which has high morbidity, but will be followed with ultrasound scans of the SN-positive region(s) at their follow-up visits every third month for two years, then every six month for three years, except if PET-CT is performed.",
author = "Mette Haldrup and Stolle, {Lars B} and H{\"o}lmich, {Lisbeth Rosenkrantz} and Annette Chakera",
year = "2018",
language = "Dansk",
volume = "180",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "41",

}

RIS

TY - JOUR

T1 - Sentinel node-positivt melanom

AU - Haldrup, Mette

AU - Stolle, Lars B

AU - Hölmich, Lisbeth Rosenkrantz

AU - Chakera, Annette

PY - 2018

Y1 - 2018

N2 - Two recent randomised studies found no survival difference in patients, who had melanoma with metastasis to the sentinel node (SN) and underwent immediate complete lymph node dissection (CLND), compared with patients, who were followed closely with ultrasound scans and only underwent CLND if metastases developed. From 2018, the Danish guidelines concur: SN-positive patients will no longer undergo routine CLND, which has high morbidity, but will be followed with ultrasound scans of the SN-positive region(s) at their follow-up visits every third month for two years, then every six month for three years, except if PET-CT is performed.

AB - Two recent randomised studies found no survival difference in patients, who had melanoma with metastasis to the sentinel node (SN) and underwent immediate complete lymph node dissection (CLND), compared with patients, who were followed closely with ultrasound scans and only underwent CLND if metastases developed. From 2018, the Danish guidelines concur: SN-positive patients will no longer undergo routine CLND, which has high morbidity, but will be followed with ultrasound scans of the SN-positive region(s) at their follow-up visits every third month for two years, then every six month for three years, except if PET-CT is performed.

M3 - Tidsskriftartikel

C2 - 30327078

VL - 180

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 41

M1 - V03180192

ER -

ID: 219535658